Literature DB >> 5582075

The electrophoretic mobility of BP8 ascites tumour cells and allergized lymph-node cells after treatment with inflammatory mediators, ptomaines, polyamines, antisera and neuraminidase or heparin.

D M Mitchell, D B Cater.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5582075      PMCID： PMC2072257     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN： 0007-1021


× No keyword cloud information.
  12 in total

1.  Effect of A.L.S. and prednisolone on the electrophoretic mobility of lymphocytes.

Authors:  G Bert; D Lajolo di Cossano; P Pecco; D Mazzei
Journal:  Lancet       Date:  1970-02-14       Impact factor: 79.321

Review 2.  Glycoproteins in membranes.

Authors:  G M Cook
Journal:  Biol Rev Camb Philos Soc       Date:  1968-08

Review 3.  Cell membrane properties in neoplasia.

Authors:  P S Vassar; G V Seaman; D E Brooks
Journal:  Proc Can Cancer Conf       Date:  1967

4.  An electron-microscope study of the effects of lysolecithin on BP8 ascites-tumour cells and phagocytes of mice, compared with the effects of a specific anti-tumour serum plus complement.

Authors:  P J Wilkinson; D B Cater
Journal:  J Pathol       Date:  1969-02       Impact factor: 7.996

5.  Effect of lysine polypeptides on the surface charge of normal and cancer cells.

Authors:  J N Mehrishi
Journal:  Eur J Cancer       Date:  1969-11       Impact factor: 9.162

6.  A study of the mechanisms of attachment of allergised lymphocytes to BP8 ascites tumour cells.

Authors:  P J Lee; D B Cater
Journal:  Br J Exp Pathol       Date:  1969-12

7.  The effect of lymph-node cells from specifically sensitised mice, on the growth of the BP8 ascites tumor "in vivo" and "in vitro".

Authors:  G A Rook; D B Cater
Journal:  Br J Exp Pathol       Date:  1968-06

8.  Changes in the electrophoretic mobility of mouse lymphocytes, thymocytes, macrophages and tumour cells following immunisation.

Authors:  F Hartveit; D B Cater; J N Mehrishi
Journal:  Br J Exp Pathol       Date:  1968-12

9.  Surface properties of normal human circulating small lymphocytes and lymphocytes in chronic lymphocytic leukaemia: separation, adhesiveness and electrokinetic properties.

Authors:  A E Thomson; J N Mehrishi
Journal:  Eur J Cancer       Date:  1969-05       Impact factor: 9.162

10.  The effect on the growth of BP8 ascites tumour in C3H-C57 or C3H mice of "lymphocyte preparations" from C57 mice injected with BP8 cells and Freund's adjuvant.

Authors:  D B Cater; H Waldmann
Journal:  Br J Cancer       Date:  1967-03       Impact factor: 7.640
View more
  6 in total

1.  Influence of mono- and multivalent cations on the electrokinetic properties of normal human lymphoid and burkitt lymphoma cells.

Authors:  L Kiremidjian-Schumacher; G Stotzky
Journal:  Experientia       Date:  1976-03-15

2.  Electrophoresis of lymphoid cells. Characterization of human B and T cells in peripheral lymphoid tissues.

Authors:  J N Wiig; S Thunold
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

3.  A study of the cell surface of tumour, foetal and lymph-node cells by cell electrophoresis after antibody and enzymic treatment.

Authors:  J Woo; D B Cater
Journal:  Biochem J       Date:  1972-08       Impact factor: 3.857

4.  A method of separating the lymph-node cells, of C57 BL mice allergized with BP8 ascites tumour, into two fractions with a fast and slow electrophoretic mobility: demonstration that only the "fast LNC" will protect C3H mice against challenge with the tumour.

Authors:  C B Thomas; D B Cater
Journal:  Br J Exp Pathol       Date:  1972-04

5.  Corticosteroids decrease the expression of beta 2-microglobulin and histocompatibility antigens on human peripheral blood lymphocytes in vitro.

Authors:  M Hokland; B Larsen; I Heron; T Plesner
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

6.  Factors inducing a loss of net negative surface charge on spleen cells of mice grafted with a slow-growing tumour.

Authors:  D Vaillier; J Vaillier
Journal:  Br J Cancer       Date:  1980-11       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.